ResearcherHarvard UniversityActive in the last 2 years

Abolfazl Salari

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0009-6730-132X; OpenAlex author ID A5015619711. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2026: 1 paper

Papers 1

Adjuvant chemotherapy in patients with pancreatic ductal adenocarcinoma after pathologic complete response to neoadjuvant treatment: necessary or overtreatment? Co-author DOI 10.1016/j.gassur.2026.102542 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

George Molina · 1 shared paper, 2026 · strength 0.36
- Paper Adjuvant chemotherapy in patients with pancreatic ductal adenocarcinoma after pathologic complete response to neoadjuva… DOI 10.1016/j.gassur.2026.102542 ↗
Chukwuma N Eruchalu · 1 shared paper, 2026 · strength 0.36
- Paper Adjuvant chemotherapy in patients with pancreatic ductal adenocarcinoma after pathologic complete response to neoadjuva… DOI 10.1016/j.gassur.2026.102542 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.